(E)-2-Methoxy-4-(3-(4-Methoxyphenyl) Prop-1-en-1-yl) Phenol Suppresses Breast Cancer Progression by Dual-Regulating VEGFR2 and PPARγ

• Published in: Journal of microbiology and biotechnology Vol. 34; no. 2; pp. 240 - 248
• Main Authors: Na-yeon Kim, Hyo-min Park, Hee Pom Lee, Jin Tae Hong, Do-young Yoon
• Format: Journal Article
• Language: Korean
• Published: 한국미생물생명공학회 28.02.2024
• Subjects: AKT; anti-cancer effect; Breast cancer treatment; MMPP; PPARγ; VEGFR2; Breast cancer treatment; VEGFR2; AKT; MMPP; anti-cancer effect; PPAR{\gamma}
• ISSN: 1017-7825; 1738-8872

In cancer treatment, multi-target approach has paid attention to a reasonable strategy for the potential agents. We investigated whether (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol (MMPP) could exert an anticancer effect by dual-regulating VEGFR2 and PPARγ. MMPP showed modulating effects in TNBC type (MDA-MB-231 and MDA-MB-468) and luminal A type (MCF7) breast cancer cell lines. MMPP enhanced PPARγ transcriptional activity and inhibited VEGFR2 phosphorylation. MMPP-induced signaling by VEGFR2 and PPARγ ultimately triggered the downregulation of AKT activity. MMPP exhibited anticancer effects, as evidenced by growth inhibition, inducement of apoptosis, and suppression of migration and invasion. At the molecular level, MMPP activated pro-apoptotic proteins (caspase3, caspase8, caspase9, and bax), while inhibiting the anti-apoptotic proteins (bcl2). Additionally, MMPP inhibited the mRNA expressions of EMT-promoting transcription factors. Therefore, our findings showed molecular mechanisms of MMPP by regulating VEGFR2 and PPARγ, and suggested that MMPP has potential to treat breast cancer.